"Conveniently located in Bethlehem Township at the intersection of Route 33 and Interstate 78, St. Luke’s Anderson Campus is designed to provide high quality, efficient health care services in an aesthetically pleasing environment. A combination of a state-of-the-art facility, clinical expertise and great healthcare providers working together to offer patient-centered care. The campus offers ample parking, spacious private patient rooms and a family friendly emergency room. A new Women & Babies Pavilion will be opening in January of 2020, The new Women & Babies Pavilion will double the size of the existing hospital on the 500-acre Anderson Campus in Bethlehem Township. The four-floor, 180,000-square-foot facilit..."

During the past decade, Saint Luke's Hospital-Anderson Campus conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's Hospital-Anderson Campus" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Clinigen, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's Hospital-Anderson Campus" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Carl Zeiss Meditec AG" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Prometheus Laboratories" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's Hospital-Anderson Campus" are "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials), "ALK Positive" (1 trials), "Clinical Stage II Esophageal Adenocarcinoma AJCC v8" (1 trials) and "Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8" (1 trials). Many other conditions were trialed in "Saint Luke's Hospital-Anderson Campus" in a lesser frequency.

Most popular intervention types in "Saint Luke's Hospital-Anderson Campus" are "Drug" (14 trials), "Procedure" (7 trials), "Biological" (6 trials), "Other" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (7 trials), "Biospecimen Collection" (5 trials), "Positron Emission Tomography" (4 trials), "Atezolizumab" (3 trials) and "Magnetic Resonance Imaging" (3 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's Hospital-Anderson Campus" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Luke's Hospital-Anderson Campus". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Saint Luke's Hospital-Anderson Campus, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's Hospital-Anderson Campus, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".